Skip to content
★ Sign in to follow
MH

MedSci Healthcare Holdings Ltd. Stock: price and insider trades · Hong Kong

HK·Mcap HK$465.4MHealth Care

No insider purchase over the last 90 days. The latest, by Li Xinmei, was filed 09 Jan 2025.

MedSci Healthcare Holdings Ltd.: what insiders have been doing

MedSci Healthcare Holdings Ltd. belongs to the Health Care sector. Filings by its managers are published through HKEX. The past year has been quiet: not a single insider filing for MedSci Healthcare Holdings Ltd. The previous disclosure was published on 7 November 2025.

Our records for MedSci Healthcare Holdings Ltd. go back to 2023, with 2 purchases and 30 sales on the open market in total.

For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and Vetoquinol SA. Source: insider filings from HKEX. Past trades are no guide to future returns.

Insider Decl.
39
Thresholds
n/a
Buy Volume
€6,137
2 ops. · all time
Sell Volume
€545,441
30 ops. · all time

Who traded when

BuySale
Li Xinmei1 buy

Since the insiders bought

  • Filed 09 Jan 2025 · 669 days ago · €6,137
    +65.8%
    Entry HK$0.79 · Close at T+365 HK$1.31

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 12,954 of 26,911 companies
52.4
score / 100
Value
41
Quality
64
FCF yld0.4%
Earn yld3.9%
EV/EBITDA18.6x
ROE1.3%
Gross mgn59%
Net mgn6.6%
Debt/EBITDA0.2x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

HK$0.85
Analyst consensus
·
Income statement
RevenueHK$270.4M
Gross profitHK$160.4M59% margin
EBITDAHK$25.4M9% margin
Net incomeHK$17.9M5.8% margin
Valuation
PER (trailing)28.3x
P/Book0.3x
Beta1.00
Balance sheet & cash
Market capHK$465.4M
Total debtHK$6.3M
Free Cash FlowHK$2M
Debt / Equity0%
Profitability & ownership
ROE1.3%
ROA0.7%
% insiders79.7%
% institutions0.0%
Last declaration on 7 November 2025
Declarations39 total
  • ●
    DirectorExecutives
    0HKEX
    65,983,400 sharesShareXHKGHKEX:DA20251107E00540
  • ▲
    DirectorExecutives
    49,200 HKD23HKEX
    60,000 shares@ HK$0.822.7% of flowShareXHKGHKEX:DA20250109E00085
    Canonical exit: 6 Apr 2025 (T+90)
  • ▲
    DirectorExecutives

    Same trade as the filing by Li Xinmei, counted once

    49,200 HKD23HKEX
    60,000 shares@ HK$0.822.7% of flowShareXHKGHKEX:DA20250109E00084
    Canonical exit: 6 Apr 2025 (T+90)
  • ▼
    DirectorExecutives
    175,800 HKD27HKEX
    60,000 shares@ HK$2.936.4% of flowShareXHKGHKEX:DA20240522E00455
  • ▼
    DirectorExecutives
    89,700 HKD26HKEX
    30,000 shares@ HK$2.993.3% of flowShareXHKGHKEX:DA20240522E00454
  • ▼
    DirectorExecutives
    2M HKD34HKEX
    564,250 shares@ HK$2.695179.3% of flowShareXHKGHKEX:DA20240517E00519
  • ▼
    DirectorExecutives
    515,106 HKD28HKEX
    180,000 shares@ HK$2.861718.8% of flowShareXHKGHKEX:DA20240517E00514
  • ▼
    DirectorExecutives
    343,407 HKD28HKEX
    135,750 shares@ HK$2.529717.9% of flowShareXHKGHKEX:DA20240517E00518
  • ▼
    DirectorExecutives
    63,800 HKD26HKEX
    25,000 shares@ HK$2.5522.3% of flowShareXHKGHKEX:DA20240517E00515
  • ▼
    DirectorExecutives

    Same trade as the filing by Li Xinmei, counted once

    343,407 HKD28HKEX
    135,750 shares@ HK$2.529717.9% of flowShareXHKGHKEX:DA20240517E00520
  • ▼
    DirectorExecutives

    Same trade as the filing by Li Xinmei, counted once

    2M HKD34HKEX
    564,250 shares@ HK$2.695179.3% of flowShareXHKGHKEX:DA20240517E00521
  • ▼
    DirectorExecutives
    180,103 HKD12HKEX
    70,000 shares@ HK$2.57296.6% of flowShareXHKGHKEX:DA20240514E00533
  • ▼
    DirectorExecutives
    254,100 HKD12HKEX
    100,000 shares@ HK$2.5419.3% of flowShareXHKGHKEX:DA20240514E00534
  • ▼
    DirectorExecutives
    26,500 HKD11HKEX
    10,000 shares@ HK$2.651.0% of flowShareXHKGHKEX:DA20240514E00532
  • ▼
    DirectorExecutives
    79,599 HKD11HKEX
    30,000 shares@ HK$2.65332.9% of flowShareXHKGHKEX:DA20240509E00395
  • ▼
    DirectorExecutives
    291,698 HKD12HKEX
    110,000 shares@ HK$2.651810.7% of flowShareXHKGHKEX:DA20240509E00394
  • ▼
    DirectorExecutives
    300,128 HKD12HKEX
    112,500 shares@ HK$2.667811.0% of flowShareXHKGHKEX:DA20240508E00483
  • ▼
    DirectorExecutives
    76,599 HKD11HKEX
    30,000 shares@ HK$2.55332.8% of flowShareXHKGHKEX:DA20240503E00309
  • ▼
    DirectorExecutives
    178,997 HKD12HKEX
    70,000 shares@ HK$2.55716.6% of flowShareXHKGHKEX:DA20240503E00310
  • ▼
    DirectorExecutives
    74,301 HKD11HKEX
    30,000 shares@ HK$2.47672.7% of flowShareXHKGHKEX:DA20240426E00397
  • ▼
    DirectorExecutives
    49,450 HKD11HKEX
    20,000 shares@ HK$2.47251.8% of flowShareXHKGHKEX:DA20240426E00399
  • ▼
    DirectorExecutives
    24,300 HKD11HKEX
    10,000 shares@ HK$2.430.9% of flowShareXHKGHKEX:DA20240426E00400
  • ▼
    DirectorExecutives
    25,620 HKD11HKEX
    10,500 shares@ HK$2.440.9% of flowShareXHKGHKEX:DA20240426E00401
  • ▼
    DirectorExecutives
    51,050 HKD11HKEX
    20,000 shares@ HK$2.55251.9% of flowShareXHKGHKEX:DA20240426E00402
  • ▼
    DirectorExecutives
    25,300 HKD11HKEX
    10,000 shares@ HK$2.530.9% of flowShareXHKGHKEX:DA20240426E00403

25 of 39 declarations

About MedSci Healthcare Holdings Ltd.

MedSci Healthcare Holdings Ltd. is a company listed on the Hong Kong Stock Exchange, specializing in the healthcare sector. It focuses on developing and providing innovative solutions to enhance healthcare services.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations